A 68-year-old man arrives at the emergency department reporting two days of progressively worsening dyspnea and an inability to lie flat without severe respiratory distress. He has a past medical history of chronic obstructive pulmonary disease (COPD), diet-controlled type 2 diabetes mellitus, and hypertension. Current medications include inhaled tiotropium and oral amlodipine. His temperature is (), blood pressure is , pulse is , and respiratory rate is . Pulse oximetry indicates an oxygen saturation of on room air. Physical examination reveals a patient in moderate respiratory distress using accessory muscles. Jugular venous pressure is elevated to above the sternal angle. Pulmonary auscultation reveals a prolonged expiratory phase with diffuse bilateral wheezing and scattered crackles at the lung bases. Cardiac examination shows tachycardia with a regular rhythm and an audible S3 gallop. There is pitting edema in the lower extremities bilaterally.
Laboratory results are as follows:
Leukocyte count:
Thyroid-stimulating hormone (TSH): (Normal: )
Free T4: (Normal: )
N-terminal pro-B-type natriuretic peptide (NT-proBNP):
Arterial blood gas analysis on room air reveals:
pH:
:
:
:
A portable chest radiograph displays cardiomegaly, bilateral pleural effusions, prominent upper lobe pulmonary vessels, and hyperinflated lung fields. Which of the following is the most appropriate next step in the management of this patient?
- Administration of intravenous furosemide and noninvasive positive pressure ventilationCevap
- BAdministration of systemic glucocorticoids and scheduled nebulized ipratropium-albuterol
- CInfusion of intravenous sodium bicarbonate for an uncompensated metabolic acidosis
- DInitiation of empiric intravenous vancomycin and piperacillin-tazobactam
- EInitiation of methimazole to treat high-output cardiac failure